CD44 and breast carcinoma: The fact that the primary CD44 ligand, HA, is also frequently overexpressed in malignant cancers and has been shown to be an independent prognostic factor for overall survival in breast cancers [19] further suggests a role for CD44-mediated signalling in breast cancer progression.